Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
In AL amyloidosis patients undergoing ASCT, higher eGFR values were associated with longer OS, patients with kidney amyloidosis stage III at baseline had inferior OS, and OS was better in those who had a complete kidney response.”
Title: The Association of Kidney Function on Survival in Patients with AL Amyloidosis after Autologous Stem Cell Transplantation
Authors: Umut Selamet, Kole Joachim, Heather Lin, Gabriela Rondon, Charles S. Martinez, Ruby Delgado, Valda Page, Shveta S. Motwani, Berkay Dincer, Giada Bianchi, Muzaffar Qazilbash, Naoka Murakami, and Ala Abudayyeh
You can read the Full Article in Kidney360.
You can find more posts featuring Robert Orlowski on OncoDaily.
